Study population characteristics

- Feel4DM
-saaristo et al

# in Literature review .. there should be a ‘FLOW CHART for study selection process’/ at least
write the process of selection of studies

# FINDRISC scote Table for different studies

#
References:
Roden, M., & Shulman, G. I. (2019, December 4). The integrative biology of type 2 diabetes.
Nature, 576(7785), 51–60. https://doi.org/10.1038/s41586-019-1797-8
Multifactorial Intervention and Cardiovascular Disease in Type 2 Diabetes. (2003, May 8). New
England Journal of Medicine, 348(19), 1925–1927. https://doi.org/10.1056/nejm200305083481916
Suh, D. C., Choi, I. S., Plauschinat, C., Kwon, J., & Baron, M. (2010, November). Impact of
comorbid conditions and race/ethnicity on glycemic control among the US population with type 2
diabetes, 1988–1994 to 1999–2004. Journal of Diabetes and Its Complications, 24(6), 382–391.
https://doi.org/10.1016/j.jdiacomp.2009.07.001
World Health Organization. (2020, April 1). Obesity and overweight. https://www.who.int/news-
room/fact-sheets/detail/obesity-and-overweight
Taylor, R., Al-Mrabeh, A., & Sattar, N. (2019, September). Understanding the mechanisms of
reversal of type 2 diabetes. The Lancet Diabetes & Endocrinology, 7(9), 726–736.
https://doi.org/10.1016/s2213-8587(19)30076-2
Huang, L. H., Liao, Y. L., & Hsu, C. H. (2012, October). Waist circumference is a better predictor
than body mass index of insulin resistance in type 2 diabetes. Obesity Research & Clinical Practice,
6(4), e314–e320. https://doi.org/10.1016/j.orcp.2011.11.003
Martín-Timón, I. (2014). Type 2 diabetes and cardiovascular disease: Have all risk factors the same
strength? World Journal of Diabetes, 5(4), 444. https://doi.org/10.4239/wjd.v5.i4.444
Rizvi, A. A. (2017, October 31). Editor’s Pick: Addressing Hypertension in the Patient with Type 2
Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach. EMJ Diabetes, 84–92.
https://doi.org/10.33590/emjdiabet/10312697
Song, Y., Liu, X., Zhu, X., Zhao, B., Hu, B., Sheng, X., Chen, L., Yu, M., Yang, T., & Zhao, J.
(2016, November 2). Increasing trend of diabetes combined with hypertension or
hypercholesterolemia: NHANES data analysis 1999–2012. Scientific Reports, 6(1).
https://doi.org/10.1038/srep36093
Patterson, R., McNamara, E., Tainio, M., de Sá, T. H., Smith, A. D., Sharp, S. J., Edwards, P.,
Woodcock, J., Brage, S., & Wijndaele, K. (2018, March 28). Sedentary behaviour and risk of all-
cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and
dose response meta-analysis. European Journal of Epidemiology, 33(9), 811–829.
https://doi.org/10.1007/s10654-018-0380-1
Waugh, N., Shyangdan, D., Taylor-Phillips, S., Suri, G., & Hall, B. (2013, August). Screening for
type 2 diabetes: a short report for the National Screening Committee. Health Technology
Assessment, 17(35). https://doi.org/10.3310/hta17350
Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin. (2003,
March). Obstetrical & Gynecological Survey, 58(3), 182–183.
https://doi.org/10.1097/01.ogx.0000055759.75837.e7
Laatikainen, T., Dunbar, J. A., Chapman, A., Kilkkinen, A., Vartiainen, E., Heistaro, S., Philpot, B.,
Absetz, P., Bunker, S., O’Neil, A., Reddy, P., Best, J. D., & Janus, E. D. (2007, September 19).
Prevention of Type 2 Diabetes by lifestyle intervention in an Australian primary health care setting:
Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health, 7(1).
https://doi.org/10.1186/1471-2458-7-249
Nai-arun, N., & Moungmai, R. (2015). Comparison of Classifiers for the Risk of Diabetes
Prediction. Procedia Computer Science, 69, 132–142. https://doi.org/10.1016/j.procs.2015.10.014
Hahn, S. J., Kim, S., Choi, Y. S., Lee, J., & Kang, J. (2022, December). Prediction of type 2
diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning
analysis of population-based 10-year prospective cohort study. EBioMedicine, 86, 104383.
https://doi.org/10.1016/j.ebiom.2022.104383
Liu, J., Wang, L., Qian, Y., Shen, Q., Yang, M., Dong, Y., Chen, H., Yang, Z., Liu, Y., Cui, X., Ma,
H., & Jin, G. (2022, August 17). Metabolic and Genetic Markers Improve Prediction of Incident
Type 2 Diabetes: A Nested Case-Control Study in Chinese. The Journal of Clinical Endocrinology
& Metabolism, 107(11), 3120–3127. https://doi.org/10.1210/clinem/dgac487
Ramezankhani, A., Pournik, O., Shahrabi, J., Azizi, F., Hadaegh, F., & Khalili, D. (2014, December
1). The Impact of Oversampling with SMOTE on the Performance of 3 Classifiers in Prediction of
Type 2 Diabetes. Medical Decision Making, 36(1), 137–144.
https://doi.org/10.1177/0272989x14560647
Garcia-Carretero, R., Vigil-Medina, L., & Barquero-Perez, O. (2021, May 1). The Use of Machine
Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the
Development of Type 2 Diabetes Mellitus. Metabolic Syndrome and Related Disorders, 19(4), 240–
248. https://doi.org/10.1089/met.2020.0139
Lindström, J., & Tuomilehto, J. (2003). The diabetes risk score: a practical tool to predict type 2
diabetes risk. Diabetes care, 26(3), 725–731. https://doi.org/10.2337/diacare.26.3.725
Mavrogianni, C., Lambrinou, C. P., Androutsos, O., Lindström, J., Kivelä, J., Cardon, G., Huys, N.,
Tsochev, K., Iotova, V., Chakarova, N., Rurik, I., Moreno, L. A., Liatis, S., Makrilakis, K., &
Manios, Y. (2019, April). Evaluation of the Finnish Diabetes Risk Score as a screening tool for
undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale
European cohort. The Feel4Diabetes-study. Diabetes Research and Clinical Practice, 150, 99–110.
https://doi.org/10.1016/j.diabres.2019.02.017
Jølle, A., Midthjell, K., Holmen, J., Carlsen, S. M., Tuomilehto, J., Bjørngaard, J. H., & Åsvold, B.
O. (2019, November). Validity of the FINDRISC as a prediction tool for diabetes in a contemporary
Norwegian population: a 10-year follow-up of the HUNT study. BMJ Open Diabetes Research &
Care, 7(1), e000769. https://doi.org/10.1136/bmjdrc-2019-000769
Lim, H. M., Chia, Y. C., & Koay, Z. L. (2020, October). Performance of the Finnish Diabetes Risk
Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of
undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care. Primary Care Diabetes,
14(5), 494–500. https://doi.org/10.1016/j.pcd.2020.02.008
Bernabe-Ortiz, A., Perel, P., Miranda, J. J., & Smeeth, L. (2018, December). Diagnostic accuracy of
the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
Primary Care Diabetes, 12(6), 517–525. https://doi.org/10.1016/j.pcd.2018.07.015
Nordström, T., Miettunen, J., Auvinen, J., Ala-Mursula, L., Keinänen-Kiukaanniemi, S., Veijola, J.,
Järvelin, M. R., Sebert, S., & Männikkö, M. (2021, August 30). Cohort Profile: 46 years of follow-
up of the Northern Finland Birth Cohort 1966 (NFBC1966). International Journal of Epidemiology,
50(6), 1786–1787j. https://doi.org/10.1093/ije/dyab109
Kerkelä, M., Gissler, M., Nordström, T., Ukkola, O., & Veijola, J. (2023, March 22). Association
between participation in the Northern Finland Birth Cohorts and cardiometabolic disorders. Annals
of Medicine, 55(1), 1123–1133. https://doi.org/10.1080/07853890.2023.2186478
Jarrett, R., McCartney, P., & Keen, H. (1982, February). The Bedford Survey: Ten year mortality
rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk
indices for coronary heart disease in borderline diabetics. Diabetologia, 22(2).
https://doi.org/10.1007/bf00254833
Spijkerman, A. M., Adriaanse, M. C., Dekker, J. M., Nijpels, G., Stehouwer, C. D., Bouter, L. M., &
Heine, R. J. (2002, October 1). Diabetic Patients Detected by Population-Based Stepwise Screening
Already Have a Diabetic Cardiovascular Risk Profile. Diabetes Care, 25(10), 1784–1789.
https://doi.org/10.2337/diacare.25.10.1784
Cho, N., Shaw, J., Karuranga, S., Huang, Y., da Rocha Fernandes, J., Ohlrogge, A., & Malanda, B.
(2018, April). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections
for 2045. Diabetes Research and Clinical Practice, 138, 271–281.
https://doi.org/10.1016/j.diabres.2018.02.023
Vikulova, O. K., Galstyan, G. R., & Shestakova, M. V. (2022, March 23). Effects of GLP-1RAs on
cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on
target populations from diabetes registry in Russian Federation. Diabetes Mellitus, 25(1), 61–71.
https://doi.org/10.14341/dm12803
Kong, A. P., Luk, A. O., & Chan, J. C. (2016, June). Detecting people at high risk of type 2
diabetes- How do we find them and who should be treated? Best Practice & Research Clinical
Endocrinology & Metabolism, 30(3), 345–355. https://doi.org/10.1016/j.beem.2016.06.003
Zhang, Y., Hu, G., Zhang, L., Mayo, R., & Chen, L. (2015, March 19). A Novel Testing Model for
Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults. PLOS ONE, 10(3),
e0120382. https://doi.org/10.1371/journal.pone.0120382
Brown, N., Critchley, J., Bogowicz, P., Mayige, M., & Unwin, N. (2012, December). Risk scores
based on self-reported or available clinical data to detect undiagnosed Type 2 Diabetes: A
systematic review. Diabetes Research and Clinical Practice, 98(3), 369–385.
https://doi.org/10.1016/j.diabres.2012.09.005
Arnardóttir, E., Sigurðardóttir, R. K., Graue, M., Kolltveit, B. C. H., & Skinner, T. (2023, January
31). Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed
individuals and those at risk of diabetes in primary care. BMC Public Health, 23(1).
https://doi.org/10.1186/s12889-023-15122-y